Recs

6

5-Star Stocks Poised to Pop: Dolby Labs

Based on the aggregated intelligence of 120,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, audio technology company Dolby Labs (NYSE: DLB  ) has earned a coveted five-star ranking. Our data has shown that five-star stocks outperform the market by a significant margin; conversely, one-star stocks have woefully lagged the market average.

With that in mind, let's take a closer look at Dolby's business and see what CAPS investors are saying about the stock right now.

Dolby facts

Headquarters (founded)

San Francisco, California (1965)

Market Cap

$3.10 billion

Industry

Diversified Electronics

TTM Revenue

$640.2 million

Management

Founder/Chairman Ray Dolby

CEO N. William Jasper

Return on Equity (average last three years)

19.7%

Competitors

Sony (NYSE: SNE  ) ,

DTS (Nasdaq: DTSI  )

CAPS members bullish on DLB also bullish on

Apple (Nasdaq: AAPL  ) ,

Cemex (NYSE: CX  )

CAPS members bearish on DLB also bearish on

Ford Motor (NYSE: F  ) ,

Netflix (Nasdaq: NFLX  )

Sources: Capital IQ, a division of Standard & Poor's, and Motley Fool CAPS. TTM = trailing 12 months.

Over on CAPS, fully 2,738 of the 2,800 members who have rated Dolby -- some 98% -- believe the stock will outperform the S&P 500 going forward. These Foolish bulls include jagdme and InternetSecurity.

Last week, jagdme ran down Dolby's sweet, and simple-sounding, bull case: Brand moat, solid fundamentals, good management. Poised to ride out the economic woes and thrive long-term.

In an earlier pitch from September, InternetSecurity agrees, citing Dolby's underrated brand-power as the real reason to remain bullish:

How Dolby has held onto its intellectual property and licensing even beyond the 17 years a patent would last is a mystery to me. I think it is a brand that is barely noticed by the mass consumer market even though the logo is on much of what they own. I suspect Dolby's licensing agreements of being deeply ingrained in systems and that somebody is making sure they stay that way. That will be the reason for their continued existence and success - not technological superiority or the inability of anyone to copy their technology.

What do you think about Dolby, or any other stock for that matter? Make your voice heard on Motley Fool CAPS today. More than 120,000 investors are waiting to hear what you have to say. CAPS is 100% free, so simply click here to get started.

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Apple, Dolby, and Netflix are Motley Fool Stock Advisor picks. Cemex is also a choice of Global Gains, and the Fool own shares of it. The Fool's disclosure policy always gets a perfect score.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 20, 2008, at 11:49 AM, andrelon wrote:

    I like DLB : it was a good stock to own and will be again

    when investors are dead sure about early appeciation -

    No stock is these days, but which looks close?

    A company that has quality life saving products at

    deep discounts to competitor's prices:

    The shoe fits TEVA. Their immense scale of generic medications (growing every day) cover almost all diseases, at the same time offer substantial savings compared to the big pharma prices

    wery welcome in these money scare times.

    They also have a growing armamentarium of drugs

    resulting from their own research.

    Your thoughts are appreciated.

    Lars

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 778989, ~/Articles/ArticleHandler.aspx, 2/14/2012 8:17:40 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 12,878.28 4.24 0.03%
S&P 500 1,350.50 -1.27 -0.09%
NASD 2,931.83 0.44 0.02%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/14/2012 4:01 PM
DLB $37.36 Down -0.24 -0.64%
Dolby Laboratories CAPS Rating: *****
F $12.48 Down -0.06 -0.48%
Ford CAPS Rating: ****
NFLX $123.07 Up +4.77 +4.03%
Netflix CAPS Rating: **
SNE $19.13 Down -0.35 -1.80%
Sony Corp (ADR) CAPS Rating: **
AAPL $509.46 Up +6.86 +1.36%
Apple CAPS Rating: ***
CX $8.29 Down -0.27 -3.15%
Cemex CAPS Rating: ****
DTSI $28.11 Down -0.61 -2.12%
DTS, Inc. CAPS Rating: **

Advertisement